307 related articles for article (PubMed ID: 32317009)
21. Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung Cancer.
Schrock AB; Welsh A; Chung JH; Pavlick D; Bernicker EH; Creelan BC; Forcier B; Ross JS; Stephens PJ; Ali SM; Dagogo-Jack I; Shaw AT; Li T; Ou SI; Miller VA
J Thorac Oncol; 2019 Feb; 14(2):255-264. PubMed ID: 30368012
[TBL] [Abstract][Full Text] [Related]
22. Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer.
Leong TL; Gayevskiy V; Steinfort DP; De Massy MR; Gonzalez-Rajal A; Marini KD; Stone E; Chin V; Havryk A; Plit M; Irving LB; Jennings BR; McCloy RA; Jayasekara WSN; Alamgeer M; Boolell V; Field A; Russell PA; Kumar B; Gough DJ; Szczepny A; Ganju V; Rossello FJ; Cain JE; Papenfuss AT; Asselin-Labat ML; Cowley MJ; Watkins DN
Oncogene; 2019 Mar; 38(10):1661-1675. PubMed ID: 30348992
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation biomarkers discovered
Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible.
Jensen TJ; Goodman AM; Ellison CK; Holden KA; Kato S; Kim L; Daniels GA; Fitzgerald K; McCarthy E; Nakashe P; Mazloom AR; Almasri E; McLennan G; Grosu DS; Eisenberg M; Kurzrock R
Mol Cancer Ther; 2021 Nov; 20(11):2274-2279. PubMed ID: 34465593
[TBL] [Abstract][Full Text] [Related]
26. Multiplex genomic test of mutation and fusion genes in small biopsy specimen of lung cancer.
Oshita F; Kasajima R; Miyagi Y
J Exp Ther Oncol; 2016 Jul; 11(3):189-194. PubMed ID: 28471124
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
28. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
29. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.
Guo Q; Wang J; Xiao J; Wang L; Hu X; Yu W; Song G; Lou J; Chen J
Mol Cancer; 2018 Aug; 17(1):131. PubMed ID: 30153823
[TBL] [Abstract][Full Text] [Related]
31. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
Huang W; Hu J; Yang DW; Fan XT; Jin Y; Hou YY; Wang JP; Yuan YF; Tan YS; Zhu XZ; Bai CX; Wu Y; Zhu HG; Lu SH
Am J Respir Crit Care Med; 2012 Dec; 186(11):1160-7. PubMed ID: 23043084
[TBL] [Abstract][Full Text] [Related]
32. Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations.
Nygård L; Ahlborn LB; Persson GF; Chandrananda D; Langer JW; Fischer BM; Langer SW; Gabrielaite M; Kjær A; Rosenfeld N; Mouliere F; Østrup O; Vogelius IR; Bentzen SM
PLoS One; 2020; 15(4):e0231884. PubMed ID: 32343749
[TBL] [Abstract][Full Text] [Related]
33. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
[TBL] [Abstract][Full Text] [Related]
34. Cell-free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients.
Trier Maansson C; Meldgaard P; Stougaard M; Nielsen AL; Sorensen BS
Mol Oncol; 2023 May; 17(5):722-736. PubMed ID: 36825535
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis.
Wei T; Zhang J; Li J; Chen Q; Zhi X; Tao W; Ma J; Yang J; Lou Y; Ma T; Li X; Zhang Q; Chen W; Que R; Gao S; Bai X; Liang T
Mol Oncol; 2020 Sep; 14(9):1966-1977. PubMed ID: 32593194
[TBL] [Abstract][Full Text] [Related]
36. A computational index derived from whole-genome copy number analysis is a novel tool for prognosis in early stage lung squamous cell carcinoma.
Belvedere O; Berri S; Chalkley R; Conway C; Barbone F; Pisa F; MacLennan K; Daly C; Alsop M; Morgan J; Menis J; Tcherveniakov P; Papagiannopoulos K; Rabbitts P; Wood HM
Genomics; 2012 Jan; 99(1):18-24. PubMed ID: 22050995
[TBL] [Abstract][Full Text] [Related]
37. Detection of Copy Number Alterations by Shallow Whole-Genome Sequencing of Formalin-Fixed, Paraffin-Embedded Tumor Tissue.
Van der Linden M; Raman L; Vander Trappen A; Dheedene A; De Smet M; Sante T; Creytens D; Lievens Y; Menten B; Van Dorpe J; Van Roy N
Arch Pathol Lab Med; 2019 Dec; ():. PubMed ID: 31846367
[TBL] [Abstract][Full Text] [Related]
38. Is tissue still the issue in detecting molecular alterations in lung cancer?
Liam CK; Mallawathantri S; Fong KM
Respirology; 2020 Sep; 25(9):933-943. PubMed ID: 32335992
[TBL] [Abstract][Full Text] [Related]
39. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
40. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
Heeke S; Gay CM; Estecio MR; Tran H; Morris BB; Zhang B; Tang X; Raso MG; Rocha P; Lai S; Arriola E; Hofman P; Hofman V; Kopparapu P; Lovly CM; Concannon K; De Sousa LG; Lewis WE; Kondo K; Hu X; Tanimoto A; Vokes NI; Nilsson MB; Stewart A; Jansen M; Horváth I; Gaga M; Panagoulias V; Raviv Y; Frumkin D; Wasserstrom A; Shuali A; Schnabel CA; Xi Y; Diao L; Wang Q; Zhang J; Van Loo P; Wang J; Wistuba II; Byers LA; Heymach JV
Cancer Cell; 2024 Feb; 42(2):225-237.e5. PubMed ID: 38278149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]